Zobrazeno 1 - 7
of 7
pro vyhledávání: '"M. F. G. van der Meulen"'
Autor:
P. Bruins, M. F. G. van der Meulen
Publikováno v:
Handboek PACU ISBN: 9789036828420
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7be70dba6eb4c3488ff07d8ecd246975
https://doi.org/10.1007/978-90-368-2843-7_28
https://doi.org/10.1007/978-90-368-2843-7_28
Autor:
John H. J. Wokke, W. T. M. Van Blokland, R.A. de Weger, D.F. van Wichen, M. F. G. van der Meulen, L.H. van den Berg, Jessica E. Hoogendijk
Publikováno v:
Journal of Neuroimmunology. 133:198-204
Vbeta usage of muscle-infiltrating T lymphocytes in polymyositis (PM) and sporadic inclusion body myositis (s-IBM) was correlated with clinical and histopathological features. Immunohistochemical analysis was combined with complementarity-determining
Autor:
H. J. Dinant, W. H. J. P. Linssen, Jessica E. Hoogendijk, Alexandre E. Voskuyl, M. F. G. van der Meulen, John H. J. Wokke, S Kalmijn, M. de Visser, I. M. Bronner, W. J. Van Venrooij
Publikováno v:
Annals of the rheumatic diseases, 65(11), 1456-1461. BMJ Publishing Group
Annals of the Rheumatic Diseases, 65, 11, pp. 1456-1461
Annals of the Rheumatic Diseases, 65, 1456-1461
Annals of the Rheumatic Diseases, 65, 11, pp. 1456-1461
Annals of the Rheumatic Diseases, 65, 1456-1461
Background: Although polymyositis and dermatomyositis are regarded as treatable disorders, prognosis is not well known, as in the literature long-term outcome and prognostic factors vary widely. Aim: To analyse the prognostic outcome factors in polym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcade092d0b0bab35999afd0f0b9a01d
https://pure.amc.nl/en/publications/longterm-outcome-in-polymyositis-and-dermatomyositis(1f84bad9-f299-4d41-83bf-675e60af9caf).html
https://pure.amc.nl/en/publications/longterm-outcome-in-polymyositis-and-dermatomyositis(1f84bad9-f299-4d41-83bf-675e60af9caf).html
Autor:
W. H. J. P. Linssen, Alexandre E. Voskuyl, M. de Visser, M. F. G. van der Meulen, I. M. Bronner, Huibert Burger, Jessica E. Hoogendijk, J.H.J. Wokke, W. J. Van Venrooij, H. J. Dinant
Publikováno v:
Neurology, 61(3), 316-321. Lippincott Williams and Wilkins
Neurology, 61(3), 316-321. LIPPINCOTT WILLIAMS & WILKINS
Neurology, 61(3), 316-321. LIPPINCOTT WILLIAMS & WILKINS
To the Editor: The classification of the inflammatory and immune myopathies is a complex issue. While the Bohan and Peter criteria1 have been used for almost 30 years, recent findings have brought their validity into question. For this reason, we rea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3472c56b163b87480e16cde6d573fc7
https://pure.amc.nl/en/publications/polymyositis--an-overdiagnosed-entity(9f64ab0f-775a-4e87-96f9-0f93935d7edb).html
https://pure.amc.nl/en/publications/polymyositis--an-overdiagnosed-entity(9f64ab0f-775a-4e87-96f9-0f93935d7edb).html
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 146(18)
The group of idiopathic inflammatory myopathies encompasses polymyositis, dermatomyositis and inclusion body myositis. These diseases share the following features: progressive muscle weakness, an increase in serum creatine kinase activity and the pre
Publikováno v:
Journal of neurology, 247(2), 102-105. D. Steinkopff-Verlag
To study the short-term effect of oral pulsed high-dose dexamethasone for myositis we treated eight newly diagnosed patients with three 28-day cycles of oral dexamethasone. Primary outcome measures were muscle strength, pain, and serum creatine kinas
Autor:
Alan Pestronk, Walter G. Bradley, H. J. Dinant, M. F. G. van der Meulen, Zohar Argov, J.H.J. Wokke, M. de Visser, R. L. Wortmann, CV Oddis, Alexandre E. Voskuyl, Jessica E. Hoogendijk, David Lacomis, Gerald J D Hengstman, Baziel G.M. van Engelen, S. B. Rutkove, David A. Isenberg, Huibert Burger, I.E. Lundberg, W. H. J. P. Linssen, I. M. Bronner, Frederick W. Miller, W. J. Van Venrooij, Lisa G. Rider, P. H. Plotz
Publikováno v:
Neurology. 63:402-403